FTHFX
Price
$58.28
Change
-$0.44 (-0.75%)
Updated
Sep 14 closing price
Net Assets
12.15B
GSSCX
Price
$10.54
Change
-$0.09 (-0.85%)
Updated
Sep 14 closing price
Net Assets
924.11M
Interact to see
Advertisement

FTHFX vs GSSCX

FTHFX vs GSSCX Comparison Chart in %
View a ticker or compare two or three
VS
FTHFX vs. GSSCX commentary
Sep 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTHFX is a Buy and GSSCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FTHFX has more cash in the bank: 12.1B vs. GSSCX (924M). GSSCX pays higher dividends than FTHFX: GSSCX (0.79) vs FTHFX (0.56). FTHFX was incepted earlier than GSSCX: FTHFX (15 years) vs GSSCX (29 years). GSSCX (2.19) is less costly to investors than FTHFX (0.64). GSSCX is a more actively managed with annual turnover of: 82.00 vs. FTHFX (28.00). GSSCX has a lower initial minimum investment than FTHFX: GSSCX (1000) vs FTHFX (1000000). FTHFX annual gain was more profitable for investors over the last year : 17.82 vs. GSSCX (-30.40). FTHFX return over 5 years is better than : 62.36 vs. GSSCX (-73.35).
FTHFXGSSCXFTHFX / GSSCX
Total Expense Ratio0.642.0132%
Annual Report Gross Expense Ratio0.642.1929%
Fund Existence15 years29 years-
Gain YTD16.02517.32992%
Front LoadN/AN/A-
Min. Initial Investment10000001000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets12.1B924M1,310%
Annual Yield % from dividends0.560.7971%
Returns for 1 year17.82-30.40-59%
Returns for 3 years59.81-45.58-131%
Returns for 5 years62.36-73.35-85%
Returns for 10 years237.45-72.44-328%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FFTMX23.41N/A
N/A
Fidelity Advisor Asset Manager 50% M
HWSAX94.73N/A
N/A
Hotchkis & Wiley Small Cap Value A
WASMX26.15N/A
N/A
Boston Trust Walden SMID Cap
CEMGX19.50N/A
N/A
Cullen Emerging Markets High Div C
LYFCX18.08N/A
N/A
AlphaCentric Life Sciences & Hlthcare C